Actively Recruiting
Evaluation of a Moisturizing Creams Safety and Effectiveness for Moderate to Severe Xerosis of the Lower Limbs
Led by Brainfarma Industria Química e Farmacêutica S/A · Updated on 2026-11-02
22
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the dermatological safety and effectiveness of a moisturizing cream in adults aged 35 to 65 years who have moderate to severe dryness xerosis on their lower legs. The study aims to determine if the product is well tolerated without causing irritation, improves skin hydration after single and repeated use, enhances skin barrier recovery and strength, and how participants perceive its performance. Participants will apply the moisturizing cream twice daily to their lower limbs for 28 days. The study includes clinical skin evaluations and instrumental assessments using devices called Corneometerae to measure skin hydration and Tewameterae to assess skin barrier function. Questionnaires will also be completed to capture participants views on the products performance and efficacy. During the study, participants will undergo dermatological assessments at baseline and after 28 days to evaluate skin acceptability. Skin hydration and barrier function will be measured at multiple time points after single and repeated applications. Participants will complete questionnaires on perceived product effectiveness. The study lasts 28 days with regular monitoring to track skin condition and product tolerance.
CONDITIONS
Brief Title
Dermatological Acceptability and Efficacy in Improving Xerosis, Skin Hydration, and Barrier Function
Research Team
L
Layane Melody Da Silva Reis Cavalcante
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here